Bintayan, Norie .

HRN: 22-70-87  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/14/2023
CEFTRIAXONE 1G (VIAL)
03/14/2023
03/21/2023
IV
2 Grams
Every 12 Hours
Sepsis
Waiting Final Action 
03/14/2023
CEFTRIAXONE 1G (VIAL)
03/14/2023
03/21/2023
IV
2 Grams
Every 12 Hours
Sepsis
Waiting Final Action 
03/14/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
03/14/2023
03/15/2023
IVT
4.5g
Q8 Hours
Sepsis
Waiting Final Action 
03/14/2023
CEFTAZIDIME 1GM (VIAL)
03/14/2023
03/21/2023
IV
1g
Q8
CAP HR
Waiting Final Action 
03/14/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
03/14/2023
03/21/2023
IV
500mg
Q8
Sepsis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: